Firazyr & Hereditary angioedema

23.8%

of users reported Hereditary angioedema

55.5%

also reported Hospitalization

74.3%

are women

Hospitalization

55.5%

Severe reaction

40.4%

Life-threatening condition

3.1%

Death

0.5%

Disability

0.5%

Firazyr: general information

10 - 19 years

1.6%

20 - 29 years

13.3%

30 - 39 years

20.6%

40 - 49 years

22.3%

50 - 59 years

19.6%

60 - 69 years

14.1%

70 - 79 years

8.2%

80 - 89 years

0.5%